ODI Pharma AB (publ) (NGM:ODI)
1.210
+0.010 (0.83%)
At close: Nov 5, 2025
ODI Pharma AB Company Description
ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.
It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden.
ODI Pharma AB (publ)
| Country | Sweden |
| Founded | 2018 |
| Industry | Pharmaceutical Preparations |
| Employees | 1 |
| CEO | Jan-Mark Edewaard |
Contact Details
Address: Oestermalmstorg 1 Stockholm, 114 42 Sweden | |
| Website | odipharma.com |
Stock Details
| Ticker Symbol | ODI |
| Exchange | Nordic Growth Market |
| Fiscal Year | July - June |
| Reporting Currency | SEK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jan-Mark Edewaard | Chief Executive Officer |